Evimed Sp. z o.o.

At Evimed Sp. z o.o. in Warsaw, a major part of the clinical research focuses on immune-mediated conditions, especially alopecia areata and atopic dermatitis. These studies are designed to evaluate how well new therapies can control symptoms, improve long-term disease management, and support safer treatment options for both children and adults.

• Research on alopecia areata in pediatric patients, aiming to test whether a new treatment approach is more effective than placebo.
• Multiple studies in atopic dermatitis exploring symptom relief, treatment durability, and overall safety in moderate-to-severe disease.
• Trials assessing long-term control of eczema and related immune system processes to better understand sustained treatment benefit.

This therapeutic area represents the core of the site’s research activity, with a strong emphasis on improving care for chronic inflammatory skin disease.

The site also conducts research in skin and connective tissue diseases, with studies centered on psoriasis and actinic keratosis. These trials are focused on testing new treatment options, comparing them with standard approaches or placebo, and finding better ways to clear visible skin lesions and reduce disease burden.

• Studies in psoriasis evaluating whether new oral treatment options can improve disease control in people with mild-to-moderate symptoms.
• Research in actinic keratosis examining the effectiveness of a topical therapy for clearing precancerous skin lesions on the face or scalp.
• Work aimed at improving treatment options for chronic inflammatory skin diseases that affect comfort, appearance, and quality of life.

These trials reflect a practical focus on dermatology, where the goal is to identify therapies that are both effective and suitable for longer-term use.

Across its clinical trial portfolio, Evimed Sp. z o.o. is building experience in dermatology and immunology, with an emphasis on chronic conditions that can affect patients of all ages. The research includes studies of treatment effectiveness, safety, and tolerability, helping to shape future care for persistent inflammatory skin disorders.

• Trials involving atopic dermatitis in adults, adolescents, and children, with attention to both short-term benefit and long-term safety.
• Investigations into biologic and small-molecule therapies for inflammatory skin disease, aiming to improve disease control.
• Clinical work that supports better understanding of how new treatments perform in real patient populations with chronic skin inflammation.

Overall, the site’s research landscape is centered on advancing care for common but often difficult-to-manage skin and immune-related diseases.